Healthcare CRM Market Is Anticipated To Grow Due To Increasing demand for structured data and automation in healthcare organization Till 2025: Grand View Research, Inc.

The global healthcare CRM market is expected to reach USD 17.8 billion by 2025, growing at a CAGR of 9.1%, according to a new report by Grand View Research, Inc. Use of CRM helps healthcare organization to streamline their workflow and better manage patient care. It also helps in reducing the cost and increase the efficiency.

Vitally impacting drivers for the industry include rapidly growing percentage of aging population, rise in chronic disease incidence and advancement of new technology. Demand for operational efficiency in healthcare organization, adoption of home care/ virtual care and big data revolution is also contributing to the growth of the market. According to the study by Deloitte, 62.0% of patients are comfortable with online consultation with doctor.

Shift from volume to value based care and rise of consumerism in healthcare organization is also expected to contribute significantly to the growth of global healthcare CRM space.

U.S. Healthcare CRM market revenue, by technology, 2014 - 2025 (USD Billion)



Browse full research report on Healthcare CRM Market

Further key findings from the report suggest:

  • Based on product, individual CRM is expected to witness lucrative growth during the forecast period owing to consolidation of hospital and small healthcare providers which would increase the focus on direct to patient marketing to attract new patients. Combination of individual and referral CRM is expected to be the leading segment during the forecast period.
  • Based on application, service outreach is expected to be the major segment during the forecast period. Case management and coordinated care is expected to show the highest growth owning to rise in demand for collaborative care.
  • North America and Europe is expected to be the major regions for the growth of this industry. Emerging regions such as Asia Pacific and MEA are expected to show lucrative growth during the forecast period owning to changing healthcare system and demand for collaborative care.
  • Few of the players in this market are IBM, salesforce.com, Siemens Healthineers, SAP, Accenture, Oracle, Microsoft, Amdocs Ltd., Anthelio Healthcare Solutions, AllScripts Healthcare Solutions Inc., NetSuite, Cerner
  • A common trend observed is the rising partnerships among market players for innovation by leveraging each other competencies. For instance, Salesforce expanded its presence in IT through the launch of cloud, with collaboration of major industry partner such as Centura Health, Philips, Deloitte Digital and Accenture.
 About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more